Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist

European Journal of Pharmacology

Volumn 406, Issue 3, 2000, Pages 345-354

  Halldner, Linda ^a   Lozza, Gianluca ^b   Lindström, Karin ^a   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Schering Plough Research Institute   (Italy)

Author keywords

Adenosine receptor; Autoradiography; Caffeine; Dopamine receptor; In situ hybridization; Locomotion

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; APOMORPHINE; CAFFEINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; RACLOPRIDE; TRITIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG TOLERANCE; GENE EXPRESSION REGULATION; IMMEDIATE EARLY GENE; IN SITU HYBRIDIZATION; LOCOMOTION; MALE; MOTOR ACTIVITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMAL; APOMORPHINE; CAFFEINE; DRUG TOLERANCE; GENES, IMMEDIATE-EARLY; MALE; MOTOR ACTIVITY; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TRIAZOLES;

EID: 0034693293     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00682-8     Document Type: Article

References (37)

1. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors
2. 2 receptors
3. Adenosine A(2A) receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats
4. Adenosine-dopamine interactions in the brain
5. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
6. Tolerance to caffeine-induced stimulation of locomotor activity in rats
7. Dopamine receptors and phosphodiesterases
8. Adenosine actions and adenosine receptors after 1 week treatment with caffeine
9. Effect of some phosphodiesterase inhibitors on central dopamine mechanisms
10. 3H]SCH 58261, a selective adenosine A(2A) receptor antagonist, is a useful ligand in autoradiographic studies
11. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use
12. Action of caffeine and theophyllamine on supersensitive dopamine receptors: Considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists
13. 2 receptor agonists but not to their synergistic interaction
14. Does adenosine receptor blockade mediate caffeine-induced rotational behavior?
15. Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine
16. Tolerance to behavioral effects of caffeine in rats
17. Adenosine and dopamine function in the CNS
18. 2 adenosine receptor binding and on mRNA levels in rat brain
19. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat
20. Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding
21. Adenosine A(2A) antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys
22. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor
23. 1 receptor binding and sensitivity to exogenous adenosine in the in vitro hippocampal slice
24. The effect of theophylline on Parkinsonian symptoms
25. Potential role of adenosine antagonist therapy in pathological tremor disorders
26. Blockade of adenosine A(2A) receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats
27. Pharmacology of adenosine A(2A) receptors
28. 1 agonists in dopamine-denervated rats
29. Adenosine A(2A) receptor antagonists as new agents for the treatment of Parkinson's disease
30. Association of coffee and caffeine intake with the risk of Parkinson disease
31. Caffeine and the antiparkinsonian response to levodopa or piribedil
32. Caffeine mimics the effect of a dopamine D(2/3) receptor agonist on the expression of immediate early genes in globus pallidus
33. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration
34. Antagonism of adenosine A(2A) receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens
35. Distribution, biochemistry and function of striatal adenosine A(2A) receptors
36. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions
37. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A(2a) adenosine receptor antagonist